BIIB
Biogen Inc.
226.40$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -97.9% | +4,325.6% | +13.1% | +49.5% | -18.7% | -65.9% | -37.9% | +690.9% | -59.8% | +26.1% | -30.5% | – | |
| – | +12.1% | +5.3% | +7.7% | +15.0% | +0.7% | -0.4% | +6.1% | +4.1% | -1.0% | +2.1% | -200.0% | – | |
| – | -11.7% | +32.6% | -3.0% | +3.0% | +3.3% | +7.9% | -7.5% | +0.5% | -20.8% | +40.9% | -200.0% | – | |
| – | -306.1% | – | – | – | -87.9% | -1,278.4% | – | – | -162.4% | – | – | – | |
| – | -25.6% | +85.4% | -64.8% | +205.2% | -49.0% | -29.0% | -64.8% | +178.3% | -5.0% | +16.6% | -20.1% | – | |
| – | -63.0% | -89.8% | – | -353.2% | -98.4% | +154.3% | +20.5% | -38.4% | +3,409.1% | -83.0% | +1,732.6% | – | |
| – | – | – | – | -200.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -98.2% | -100.0% | – | – | – | |
| – | -177.3% | -32.8% | -44.2% | -97.3% | – | -391.1% | -49.1% | +1,012.8% | +5.1% | -68.0% | – | – | |
| – | – | – | +3,306.1% | -125.1% | – | -67.0% | -28.1% | +587.9% | -177.6% | – | -645.9% | – | |
| – | -110.4% | – | +34.9% | +38.1% | -13.8% | -69.5% | -32.0% | +749.8% | -54.7% | +25.3% | -29.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.